| calcium channel, voltage-dependent, gamma subunit 5 | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | epidermal growth factor receptor | 3,3',4',5-TETRACHLOROSALICYLANILIDE | Protein Tyrosine Kinase, EGF Receptor | 66% | NoneNone | NoneNone | View | 
          
            
                | cholinergic receptor, muscarinic 4 | BITHIONOL | Muscarinic M4 | 66% | NoneNone | NoneNone | View | 
          
            
                | epidermal growth factor receptor | GRAMICIDIN | Protein Tyrosine Kinase, EGF Receptor | 66% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, nonvoltage-gated 1 alpha | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 gamma | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 beta | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, voltage-gated, type 2, alpha 1 polypeptide | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, voltage-gated, type XI, alpha | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, gamma | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, delta | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 alpha | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, voltage-gated, type X, alpha | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, voltage-gated, type IX, alpha | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, voltage gated, type VIII, alpha | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, voltage-gated, type VII, alpha | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, beta | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, alpha | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, voltage-gated, type III, alpha | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, voltage-gated, type II, beta | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, voltage-gated, type II, alpha 2 | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, voltage-gated, type I, beta | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | sodium channel, voltage-gated, type I, alpha | BROMOCRIPTINE | Sodium Channel, Site 2 | 78% | 6.692uM | 6.105uM | View | 
          
            
                | Sigma-2 Receptor | EPERISONE | Sigma2 | 78% | 1.064uM | .655uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | CITALOPRAM | Calcium Channel Type L, Phenylalkylamine | 78% | 1.025uM | .996uM | View | 
          
            
                | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | CITALOPRAM | Adrenergic, Norepinephrine Transporter | 78% | 2.196uM | 2.178uM | View | 
          
            
                | thromboxane A synthase 1 | INDINAVIR | Thromboxane Synthetase | 78% | 1.851uM | NoneNone | View | 
          
            
                | thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) | INDINAVIR | Thromboxane Synthetase | 78% | 1.851uM | NoneNone | View | 
          
            
                | adrenergic receptor, beta 2 | MONTELUKAST | Adrenergic beta2 | 78% | 3.488uM | 2.398uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2B | 1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE | Serotonin 5-HT2B | 78% | 1.508uM | .96uM | View | 
          
            
                | Sigma-2 Receptor | LOPERAMIDE | Sigma2 | 78% | 1.379uM | .848uM | View | 
          
            
                | opioid receptor, sigma 1 | PROPRANOLOL | Sigma1 | 78% | 2.87uM | 1.206uM | View | 
          
            
                | sodium channel, voltage-gated, type II, alpha 2 | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type I, beta | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type I, alpha | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, beta | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel associated protein 1 | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel associated protein 2 | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type III, beta | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type I, alpha | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type IX, alpha | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type VII, alpha | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | amiloride-sensitive cation channel 5, intestinal | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type III, beta | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type VIII, alpha polypeptide | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type XI, alpha | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type I, beta | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type 10, alpha polypeptide | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, alpha polypeptide | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type V, alpha polypeptide | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type II, beta | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 alpha | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 gamma | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 beta | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type 2, alpha 1 polypeptide | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, voltage-gated, type XI, alpha | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, gamma | CITALOPRAM | Sodium Channel, Site 2 | 77% | 2.641uM | 2.409uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 3a | MIANSERIN | Serotonin 5-HT3 | 77% | 2.746uM | .617uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 3b | MIANSERIN | Serotonin 5-HT3 | 77% | 2.746uM | .617uM | View | 
          
            
                | adrenergic receptor, beta 2 | LOPERAMIDE | Adrenergic beta2 | 77% | 3.005uM | 2.066uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2B | 4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE | Serotonin 5-HT2B | 77% | 1.549uM | .986uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | sodium channel associated protein 2 | PUROMYCIN | Sodium Channel, Site 2 | 12% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | SULCONAZOLE | Calcium Channel Type L, Dihydropyridine | 77% | 2.427uM | 1.56uM | View | 
          
            
                | phosphodiesterase 3B | DANAZOL | Phosphodiesterase PDE3 | 77% | 2.535uM | NoneNone | View | 
          
            
                | phosphodiesterase 3A | DANAZOL | Phosphodiesterase PDE3 | 77% | 2.535uM | NoneNone | View | 
          
            
                | Protein-tyrosine kinase, Fyn | SULCONAZOLE | Protein Tyrosine Kinase, Fyn | 77% | 3.704uM | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | DIETHYLSTILBESTROL | Calcium Channel Type L, Phenylalkylamine | 77% | 3.761uM | 3.65uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | OXICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.7269uM | 2.6512uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | OXICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.7269uM | 2.6512uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | OXICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.7269uM | 2.6512uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | OXICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.7269uM | 2.6512uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | OXICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.7269uM | 2.6512uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | OXICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.7269uM | 2.6512uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | OXICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.7269uM | 2.6512uM | View | 
          
            
                | cholinergic receptor, muscarinic 1 | OXICONAZOLE | Muscarinic M1 | 76% | 4.7364uM | 1.1407uM | View | 
          
            
                | Sigma-2 Receptor | PRAMOXINE | Sigma2 | 76% | 1.029uM | .633uM | View | 
          
            
                | thromboxane A synthase 1 | AMPRENAVIR | Thromboxane Synthetase | 76% | 6.727uM | NoneNone | View | 
          
            
                | thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) | AMPRENAVIR | Thromboxane Synthetase | 76% | 6.727uM | NoneNone | View | 
          
            
                | melanocortin 4 receptor | CETYLPYRIDINIUM BROMIDE | Melanocortin MC4 | 76% | 5.081uM | 4.886uM | View | 
          
            
                | dopamine receptor D1A | RALOXIFENE | Dopamine D1 | 76% | 3.864uM | 1.932uM | View | 
          
            
                | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | NATEGLINIDE | Potassium Channel [KATP] | 76% | 1.667uM | .189uM | View | 
          
            
                | ATP-binding cassette, sub-family C (CFTR/MRP), member 9 | NATEGLINIDE | Potassium Channel [KATP] | 76% | 1.667uM | .189uM | View | 
          
            
                | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | NATEGLINIDE | Potassium Channel [KATP] | 76% | 1.667uM | .189uM | View | 
          
            
                | lymphocyte protein tyrosine kinase (mapped) | TRIBROMSALAN | Protein Tyrosine Kinase, Lck | 76% | 5.015uM | NoneNone | View | 
          
            
                | tachykinin receptor 2 | CLOMIPHENE | Tachykinin NK2 | 76% | 4.525uM | 1.508uM | View | 
          
            
                | adrenergic receptor, beta 1 | ATENOLOL | Adrenergic beta1 | 76% | 1.313uM | .758uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | PERGOLIDE | Calcium Channel Type L, Phenylalkylamine | 76% | .913uM | .887uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | PERGOLIDE | Calcium Channel Type L, Phenylalkylamine | 76% | .913uM | .887uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | PERGOLIDE | Calcium Channel Type L, Phenylalkylamine | 76% | .913uM | .887uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | PERGOLIDE | Calcium Channel Type L, Phenylalkylamine | 76% | .913uM | .887uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | PERGOLIDE | Calcium Channel Type L, Phenylalkylamine | 76% | .913uM | .887uM | View | 
          
            
                | sodium channel, voltage-gated, type III, beta | PUROMYCIN | Sodium Channel, Site 2 | 12% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | PERGOLIDE | Calcium Channel Type L, Phenylalkylamine | 76% | .913uM | .887uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | PERGOLIDE | Calcium Channel Type L, Phenylalkylamine | 76% | .913uM | .887uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | PERGOLIDE | Calcium Channel Type L, Phenylalkylamine | 76% | .913uM | .887uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | PERGOLIDE | Calcium Channel Type L, Phenylalkylamine | 76% | .913uM | .887uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | PERGOLIDE | Calcium Channel Type L, Phenylalkylamine | 76% | .913uM | .887uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | PERGOLIDE | Calcium Channel Type L, Phenylalkylamine | 76% | .913uM | .887uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | PERGOLIDE | Calcium Channel Type L, Phenylalkylamine | 76% | .913uM | .887uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | PERGOLIDE | Calcium Channel Type L, Phenylalkylamine | 76% | .913uM | .887uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 1B | CYPROHEPTADINE | Serotonin 5-HT1B | 76% | 2.778uM | 1.263uM | View | 
          
            
                | cysteinyl leukotriene receptor 1 | GW-1929 | Leukotriene D4 | 76% | 10.91uM | 5.455uM | View | 
          
            
                | cysteinyl leukotriene receptor 1 | GW-1929 | Leukotriene D4 | 76% | 10.91uM | 5.455uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2C | METOCLOPRAMIDE | Serotonin 5-HT2C | 76% | 2.383uM | 1.248uM | View | 
          
            
                | histamine receptor H 2 | ECONAZOLE | Histamine H2 | 76% | 1.592uM | 1.565uM | View | 
          
            
                | melanocortin 3 receptor | MICONAZOLE | Melanocortin MC3 | 76% | 18.485uM | 16.132uM | View | 
          
            
                | melanocortin 3 receptor | MICONAZOLE | Melanocortin MC3 | 76% | 18.485uM | 16.132uM | View | 
          
            
                | cholinergic receptor, muscarinic 4 | CIGLITAZONE | Muscarinic M4 | 76% | 16.224uM | 2.263uM | View | 
          
            
                | cysteinyl leukotriene receptor 1 | DIETHYLSTILBESTROL | Leukotriene D4 | 76% | 17.745uM | 8.872uM | View | 
          
            
                | cysteinyl leukotriene receptor 1 | DIETHYLSTILBESTROL | Leukotriene D4 | 76% | 17.745uM | 8.872uM | View | 
          
            
                | androgen receptor | ESTRONE | Testosterone | 76% | 11.617uM | 7.745uM | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | AJMALINE | CYP450-2D6 Inhibition | 76% | 1uM | NoneNone | View | 
          
            
                | Cytochrom P450-1A2 monooxygenase | 3-METHYLCHOLANTHRENE | CYP450-1A2 Inhibition | 76% | .3uM | NoneNone | View | 
          
            
                | Protein-tyrosine kinase, Fyn | PACLITAXEL | Protein Tyrosine Kinase, Fyn | 76% | 23.906uM | NoneNone | View | 
          
            
                | lymphocyte protein tyrosine kinase (mapped) | TANNIC ACID | Protein Tyrosine Kinase, Lck | 76% | .079uM | NoneNone | View | 
          
            
                | leukotriene C4 synthase | TANNIC ACID | Leukotriene C4 Synthetase | 76% | 2.715uM | NoneNone | View | 
          
            
                | leukotriene C4 synthase | TANNIC ACID | Leukotriene C4 Synthetase | 76% | 2.715uM | NoneNone | View | 
          
            
                | dopamine receptor D3 | U-78517F | Dopamine D3 | 76% | 5.196uM | 1.765uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | CLOTRIMAZOLE | Calcium Channel Type L, Phenylalkylamine | 76% | 2.478uM | 2.41uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | CLOMIPHENE | Calcium Channel Type L, Dihydropyridine | 75% | 1.62uM | 1.041uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | CLOMIPHENE | Calcium Channel Type L, Dihydropyridine | 75% | 1.62uM | 1.041uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | CLOMIPHENE | Calcium Channel Type L, Dihydropyridine | 75% | 1.62uM | 1.041uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | CLOMIPHENE | Calcium Channel Type L, Dihydropyridine | 75% | 1.62uM | 1.041uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | CLOMIPHENE | Calcium Channel Type L, Dihydropyridine | 75% | 1.62uM | 1.041uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | CLOMIPHENE | Calcium Channel Type L, Dihydropyridine | 75% | 1.62uM | 1.041uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | CLOMIPHENE | Calcium Channel Type L, Dihydropyridine | 75% | 1.62uM | 1.041uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | CLOMIPHENE | Calcium Channel Type L, Dihydropyridine | 75% | 1.62uM | 1.041uM | View | 
          
            
                | adrenergic receptor, alpha 2b | GUANFACINE | Adrenergic alpha2C | 75% | 6.447uM | .937uM | View | 
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | GUANFACINE | Adrenergic alpha2C | 75% | 6.447uM | .937uM | View | 
          
            
                | adrenergic receptor, alpha 1a | VERAPAMIL | Adrenergic alpha1A | 75% | 2.092uM | .847uM | View | 
          
            
                | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | 2-ACETYLAMINOFLUORENE | Adrenergic, Norepinephrine Transporter | 75% | 8.595uM | 8.524uM | View | 
          
            
                | A3 adenosine receptor | MITOTANE | Adenosine A3 | 75% | 7.445uM | 4.208uM | View | 
          
            
                | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | N,N'-DIPHENYL-P-PHENYLENEDIAMINE | Adrenergic, Norepinephrine Transporter | 75% | .786uM | .78uM | View | 
          
            
                | 5-hydroxytryptamine receptor 6 | PROPRANOLOL | Serotonin 5-HT6 | 75% | 3.065uM | 1.423uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2C | MITOXANTRONE | Serotonin 5-HT2C | 75% | 3.5619uM | 1.8657uM | View | 
          
            
                | adrenergic receptor, alpha 2b | IRINOTECAN | Adrenergic alpha2C | 75% | 3.171uM | .461uM | View | 
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | IRINOTECAN | Adrenergic alpha2C | 75% | 3.171uM | .461uM | View | 
          
            
                | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | QUINACRINE | Adrenergic, Norepinephrine Transporter | 75% | 2.896uM | 2.872uM | View | 
          
            
                | adenosine A2a receptor | IMIQUIMOD | Adenosine A2A | 75% | 5.32uM | 2.987uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 1A | KETOTIFEN | Serotonin 5-HT1A | 75% | 2.537uM | 1.45uM | View | 
          
            
                | adrenergic receptor, alpha 1d (Non-specific probe) | KETOTIFEN | Adrenergic alpha1D | 75% | 3.727uM | 1.832uM | View | 
          
            
                | Sigma-2 Receptor | SERTRALINE | Sigma2 | 75% | 2.119uM | 1.304uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | NORTRIPTYLINE | Calcium Channel Type L, Benzothiazepine | 75% | 2.803uM | 2.492uM | View |